PleoPharma
Manufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
518 Kimberton Rd Pmb 339, Phoenixville, ...Phone Number
(610) 937-2882Website
www.pleopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About PleoPharma
PleoPharma is a pharmaceutical company focused on developing therapies to address unmet needs in the central nervous system and substance abuse areas. The company seeks to provide innovative solutions, as there are currently no FDA-approved options available for these conditions, leading to widespread suffering. PleoPharma's lead program has received strong support and successfully completed Phase 2 trials. They collaborate with healthcare providers, researchers, and investors to further their mission of addressing significant medical conditions.Explore more
PleoPharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PleoPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on PleoPharma recently announced quarterly report
Check out if PleoPharma is spiking on competitors!
Product Launch: Get notified when PleoPharma launches new products
Congratulate Masked Content for being promoted to Masked Content at PleoPharma
Check if PleoPharma has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if PleoPharma had a recent Job posting/layoffs
Funding: Get notified immidiatlly once PleoPharma has new funding data
PleoPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
PleoPharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
PleoPharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about PleoPharma.
PleoPharma financials insights
Gather financial insights about PleoPharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Private Equity
$6.2M
Series B
$36M
PleoPharma Tech Stack
A closer look at the technologies used by PleoPharma
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
Funding
Funding
Project
Intellectual Property, Legal Affairs, Pharmaceuticals
Project
Product Management, Intellectual Property, Legal Affairs
PleoPharma News & Media
PleoPharma, Inc. Announces First Patient Dosed in Pivotal Phase 3 Clinical Trial of PP-01 (CAN-004) for Mitigation of Cannabis Withdrawal Symptoms in Patients with Cannabis Use Disorder
Phase 3 trial initiation advances PP-01, an investigational, once-daily therapy for cannabis withdrawal symptoms in patients with cannabis use disorder Cannabis use disorder affects an estimated 20.6 million people in the U.S., underscoring the scale of this unmet medical need...PLEOPHARMA TO PRESENT NEWDATA ON CANNABIS WITHDRAWAL In PATIENTS WITH CANNABIS USE DISORDER AND PHASE 2 PP-01 RESULTS AT THE COLLEGE ON PROBLEMS OF DRUG DEPENDENCE 88TH ANNUAL SCIENTIFIC MEETING
Presentations will highlight the patient experience of cannabis withdrawal/cannabis use disorder and Phase 2 CAN-002 data for investigational PP-01 in adults with cannabis use disorder PHOENIXVILLE, Pa., June 15, 2026 /PRNewswire/ -- PleoPharma, a clinical-stage clinical development...PLEOPHARMA, INC. to Present at the Centri Capital Conference in New York
PHOENIXVILLE, Pa., March 30, 2026 /PRNewswire/ -- PleoPharma, Inc., a privately held company focused on finding treatments for cannabis related health issues, announced today that management will present at the Centri Capital Conference in New York City on April 14, 2026 at 8:30 a.m....
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PleoPharma
Sign Up For FreeTo access detailed company insights
PleoPharma is a pharmaceutical company focused on developing therapies to address unmet needs in the central nervous system and substance abuse areas. The company seeks to provide innovative solutions, as there are currently no FDA-approved options available for these conditions, leading to widespread suffering. PleoPharma's lead program has receiv... Read More
